|
|||||
|
 | |
| |
| |
| |
| |
| |
|
Gene: USH1C |
Gene summary for USH1C |
 Gene summary. |
| Gene information | Species | Human | Gene symbol | USH1C | Gene ID | 10083 |
| Gene name | USH1 protein network component harmonin | |
| Gene Alias | AIE-75 | |
| Cytomap | 11p15.1 | |
| Gene Type | protein-coding | GO ID | GO:0000086 | UniProtAcc | A0A0S2Z4V1 |
Top |
Malignant transformation analysis |
| Identification of the aberrant gene expression in precancerous and cancerous lesions by comparing the gene expression of stem-like cells in diseased tissues with normal stem cells |
| Malignant transformation involving gene list. |
| Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
| 10083 | USH1C | HTA11_3410_2000001011 | Human | Colorectum | AD | 2.79e-04 | 3.11e-02 | 0.0155 |
| 10083 | USH1C | HTA11_2487_2000001011 | Human | Colorectum | SER | 3.81e-09 | 6.05e-01 | -0.1808 |
| 10083 | USH1C | HTA11_1938_2000001011 | Human | Colorectum | AD | 2.98e-05 | 5.65e-01 | -0.0811 |
| 10083 | USH1C | HTA11_78_2000001011 | Human | Colorectum | AD | 1.35e-02 | 4.11e-01 | -0.1088 |
| 10083 | USH1C | HTA11_347_2000001011 | Human | Colorectum | AD | 5.53e-15 | 6.44e-01 | -0.1954 |
| 10083 | USH1C | HTA11_411_2000001011 | Human | Colorectum | SER | 8.09e-10 | 1.28e+00 | -0.2602 |
| 10083 | USH1C | HTA11_696_2000001011 | Human | Colorectum | AD | 4.65e-15 | 6.13e-01 | -0.1464 |
| 10083 | USH1C | HTA11_1391_2000001011 | Human | Colorectum | AD | 6.54e-10 | 7.45e-01 | -0.059 |
| 10083 | USH1C | HTA11_866_3004761011 | Human | Colorectum | AD | 6.04e-05 | 4.68e-01 | 0.096 |
| 10083 | USH1C | HTA11_8622_2000001021 | Human | Colorectum | SER | 2.07e-02 | 5.90e-01 | 0.0528 |
| 10083 | USH1C | HTA11_7696_3000711011 | Human | Colorectum | AD | 4.63e-02 | 2.88e-01 | 0.0674 |
| 10083 | USH1C | HTA11_99999965104_69814 | Human | Colorectum | MSS | 4.98e-02 | 3.24e-01 | 0.281 |
| 10083 | USH1C | HTA11_99999971662_82457 | Human | Colorectum | MSS | 4.80e-14 | 8.56e-01 | 0.3859 |
| 10083 | USH1C | HTA11_99999973899_84307 | Human | Colorectum | MSS | 3.69e-04 | 6.18e-01 | 0.2585 |
| 10083 | USH1C | HTA11_99999974143_84620 | Human | Colorectum | MSS | 3.99e-16 | 6.40e-01 | 0.3005 |
| 10083 | USH1C | A015-C-203 | Human | Colorectum | FAP | 6.06e-18 | -3.14e-01 | -0.1294 |
| 10083 | USH1C | A002-C-201 | Human | Colorectum | FAP | 1.94e-03 | -1.68e-01 | 0.0324 |
| 10083 | USH1C | A001-C-119 | Human | Colorectum | FAP | 3.17e-02 | -2.57e-01 | -0.1557 |
| 10083 | USH1C | A001-C-108 | Human | Colorectum | FAP | 4.87e-08 | -1.48e-01 | -0.0272 |
| 10083 | USH1C | A002-C-205 | Human | Colorectum | FAP | 4.69e-10 | -2.50e-01 | -0.1236 |
| Page: 1 2 3 4 |
| Transcriptomic changes along malignancy continuum. |
| Tissue | Expression Dynamics | Abbreviation |
| Colorectum (GSE201348) |  | FAP: Familial adenomatous polyposis |
| CRC: Colorectal cancer | ||
| Colorectum (HTA11) |  | AD: Adenomas |
| SER: Sessile serrated lesions | ||
| MSI-H: Microsatellite-high colorectal cancer | ||
| MSS: Microsatellite stable colorectal cancer | ||
| GC |  | CAG: Chronic atrophic gastritis |
| CAG with IM: Chronic atrophic gastritis with intestinal metaplasia | ||
| CSG: Chronic superficial gastritis | ||
| GC: Gastric cancer | ||
| SIM: Severe intestinal metaplasia | ||
| WIM: Wild intestinal metaplasia | ||
| Liver |  | HCC: Hepatocellular carcinoma |
| NAFLD: Non-alcoholic fatty liver disease |
| ∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
| Find out the enriched GO biological processes and KEGG pathways involved in transition from healthy to precancer to cancer |
| Figure of enriched GO biological processes. |
| Tissue | Disease Stage | Enriched GO biological Processes |
| Colorectum | AD |  |
| Colorectum | SER |  |
| Colorectum | MSS |  |
| Colorectum | MSI-H |  |
| Colorectum | FAP |  |
| ∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
| Page: 1 2 3 4 5 6 7 8 9 |
| Enriched GO biological processes. |
| GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
| GO:00085442 | Colorectum | CRC | epidermis development | 57/2078 | 324/18723 | 2.88e-04 | 4.59e-03 | 57 |
| GO:00018945 | Colorectum | CRC | tissue homeostasis | 48/2078 | 268/18723 | 5.56e-04 | 7.70e-03 | 48 |
| GO:00485931 | Colorectum | CRC | camera-type eye morphogenesis | 25/2078 | 120/18723 | 1.37e-03 | 1.50e-02 | 25 |
| GO:00099133 | Colorectum | CRC | epidermal cell differentiation | 37/2078 | 202/18723 | 1.50e-03 | 1.59e-02 | 37 |
| GO:0048592 | Colorectum | CRC | eye morphogenesis | 29/2078 | 151/18723 | 2.23e-03 | 2.17e-02 | 29 |
| GO:00353154 | Colorectum | CRC | hair cell differentiation | 12/2078 | 47/18723 | 4.33e-03 | 3.47e-02 | 12 |
| GO:00485683 | Colorectum | CRC | embryonic organ development | 65/2078 | 427/18723 | 5.15e-03 | 3.94e-02 | 65 |
| GO:0090596 | Colorectum | CRC | sensory organ morphogenesis | 42/2078 | 256/18723 | 6.22e-03 | 4.54e-02 | 42 |
| GO:00424912 | Colorectum | CRC | inner ear auditory receptor cell differentiation | 10/2078 | 38/18723 | 7.08e-03 | 4.92e-02 | 10 |
| GO:000701512 | Liver | Cirrhotic | actin filament organization | 171/4634 | 442/18723 | 3.93e-11 | 2.30e-09 | 171 |
| GO:005101712 | Liver | Cirrhotic | actin filament bundle assembly | 69/4634 | 157/18723 | 1.06e-07 | 3.05e-06 | 69 |
| GO:006157212 | Liver | Cirrhotic | actin filament bundle organization | 70/4634 | 161/18723 | 1.44e-07 | 3.87e-06 | 70 |
| GO:003253512 | Liver | Cirrhotic | regulation of cellular component size | 135/4634 | 383/18723 | 2.32e-06 | 4.26e-05 | 135 |
| GO:00447721 | Liver | Cirrhotic | mitotic cell cycle phase transition | 139/4634 | 424/18723 | 1.02e-04 | 1.06e-03 | 139 |
| GO:000701522 | Liver | HCC | actin filament organization | 252/7958 | 442/18723 | 3.83e-10 | 1.25e-08 | 252 |
| GO:00447722 | Liver | HCC | mitotic cell cycle phase transition | 240/7958 | 424/18723 | 2.47e-09 | 6.84e-08 | 240 |
| GO:003253522 | Liver | HCC | regulation of cellular component size | 217/7958 | 383/18723 | 1.28e-08 | 3.14e-07 | 217 |
| GO:005101722 | Liver | HCC | actin filament bundle assembly | 96/7958 | 157/18723 | 1.81e-06 | 2.52e-05 | 96 |
| GO:006157222 | Liver | HCC | actin filament bundle organization | 97/7958 | 161/18723 | 4.04e-06 | 5.22e-05 | 97 |
| GO:00325307 | Liver | HCC | regulation of microvillus organization | 12/7958 | 13/18723 | 2.73e-04 | 1.98e-03 | 12 |
| Page: 1 2 3 4 5 6 7 |
| Enriched KEGG pathways. |
| Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
| Page: 1 |
Top |
Cell-cell communication analysis |
| Identification of potential cell-cell interactions between two cell types and their ligand-receptor pairs for different disease states |
| Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
| Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
| Find out the significant the regulons (TFs) and the target genes of each regulon across cell types for different disease states |
| TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
| ∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
| Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
| Annotation of somatic variants for genes involved in malignant transformation |
| Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
| USH1C | SNV | Missense_Mutation | c.502N>A | p.Gly168Ser | p.G168S | Q9Y6N9 | protein_coding | deleterious(0) | probably_damaging(0.971) | TCGA-A1-A0SH-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | tc | SD | |
| USH1C | SNV | Missense_Mutation | novel | c.1149N>C | p.Gln383His | p.Q383H | Q9Y6N9 | protein_coding | tolerated_low_confidence(0.13) | possibly_damaging(0.679) | TCGA-A8-A08H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| USH1C | SNV | Missense_Mutation | c.370G>A | p.Asp124Asn | p.D124N | Q9Y6N9 | protein_coding | deleterious(0.02) | possibly_damaging(0.813) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
| USH1C | SNV | Missense_Mutation | rs201644053 | c.2500N>A | p.Asp834Asn | p.D834N | Q9Y6N9 | protein_coding | deleterious_low_confidence(0) | possibly_damaging(0.514) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| USH1C | SNV | Missense_Mutation | novel | c.1455N>T | p.Lys485Asn | p.K485N | Q9Y6N9 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.994) | TCGA-AN-A046-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD |
| USH1C | SNV | Missense_Mutation | rs774988386 | c.1754N>T | p.Ser585Phe | p.S585F | Q9Y6N9 | protein_coding | deleterious_low_confidence(0.01) | benign(0.084) | TCGA-AR-A0TX-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD |
| USH1C | SNV | Missense_Mutation | c.1954N>T | p.His652Tyr | p.H652Y | Q9Y6N9 | protein_coding | tolerated_low_confidence(0.38) | benign(0) | TCGA-BH-A0HF-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD | |
| USH1C | SNV | Missense_Mutation | rs397517883 | c.587G>A | p.Arg196Gln | p.R196Q | Q9Y6N9 | protein_coding | tolerated(0.11) | benign(0.32) | TCGA-E2-A56Z-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | arimidex | SD |
| USH1C | SNV | Missense_Mutation | c.2281N>C | p.Glu761Gln | p.E761Q | Q9Y6N9 | protein_coding | deleterious_low_confidence(0.01) | probably_damaging(0.991) | TCGA-EW-A1J5-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | adriamycin | SD | |
| USH1C | SNV | Missense_Mutation | c.2498N>G | p.Ile833Ser | p.I833S | Q9Y6N9 | protein_coding | deleterious_low_confidence(0) | probably_damaging(0.996) | TCGA-EW-A1P5-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Hormone Therapy | anastrozole | SD |
| Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 |
Top |
Related drugs of malignant transformation related genes |
| Identification of chemicals and drugs interact with genes involved in malignant transfromation |
| (DGIdb 4.0) |
| Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
| Page: 1 |
Copyright 2023-Present -The University of Texas Health Science Center at Houston |